Is Neurocrine Biosciences, Inc. (NBIX) a Buy, Sell, or Hold?
NASDAQ : NBIX
Neurocrine Biosciences, Inc. — Competitors
$166.8 USD
-$18.7 (-10.08%)
- Volume
- 4.58M
- Average Volume
- 1.29M
- Market Capitalization
- $16.77B
- P/E Ratio
- 23.66
- Dividend Yield
- 0.00%
- Price Target
- $200.00
- Year High
- $186.12
- Year Low
- $122.14
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.87
NBIX vs. The Competition
| Properties | NBIX | COO | ELAN | HOLX |
|---|---|---|---|---|
| Market Cap | $16.77B | $14.1B | $13.18B | $16.97B |
| Shares Outstanding | $100.55M | $195.03M | $499.45M | $223.24M |
| P/E Ratio | 23.66 | 61.29 | -53.01 | 31.28 |
| EPS | 6.99 | 1.21 | -0.49 | 2.42 |
| Day Low | 164.56 | 71.15 | 25.77 | 76.01 |
| Day High | 185.55 | 72.5 | 26.465 | 76.01 |
| Year Low | 122.14 | 58.89 | 13.39 | 51.9 |
| Year High | 186.12 | 89.83 | 27.72 | 76.07 |
| Average Price 50 | 167.354 | 68.0514 | 24.2682 | 75.2854 |
| Average Price 200 | 145.91216 | 73.08465 | 23.42365 | 71.27765 |
| Volume | 4.58M | 2.44M | 5.19M | 101.96M |
| Average Volume | - | - | - | - |